Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The products claim to be approved by many organisations including Diabetes Australia and often falsely represent prominent health professionals, for example endocrinologists in Australia (shown in screenshot below)
Fill out the form below and we will get back to your promptly or Give us a call during business hours
Value investors probably won't find the stock interesting, but growth investors shouldn't ignore it because of its lofty P/E ratio
Are people with a history of pancreatitis at higher risk
US$ 26.70
US$ 28.30
US$ 23.33
US$ 28.10
US$ 26.40
US$ 23.43
